Thrive Health Solutions
- IV Therapy
- Arthritis Treatment
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Englewood, CO
Englewood sits immediately south of Denver and has become a significant IV therapy cluster thanks to proximity to the Denver Tech Center, the Swedish Medical Center medical hub, and a steady professional commuter base. Clinics cluster near Swedish Medical along Hampden Avenue, in downtown Englewood, and along Broadway, with overflow from Centennial, Cherry Hills, and Littleton. HealthONE Swedish Medical Center, Porter Adventist, and Littleton Adventist anchor the clinical ecosystem supplying many medical directors. Colorado is a full-practice state for nurse practitioners, so NP-led IV clinics are common in Englewood alongside physician-director models. Altitude-driven hydration demand (roughly 5,300 feet), DTC corporate wellness spillover, and the runner and cyclist community using the South Platte Trail all sustain volume. Mobile IV services reach Cherry Hills Village, Greenwood Village, and Columbine Valley.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Colorado medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.